Vistagen Therapeutics Inc (NASDAQ:VTGN) Finds Stem Cell Partner in Bayer AG (ADR) (OTCMKTS:BAYRY) With … – Market Exclusive
|
Vistagen Therapeutics Inc (NASDAQ:VTGN) Finds Stem Cell Partner in Bayer AG (ADR) (OTCMKTS:BAYRY) With …
Market Exclusive In the meantime, the firm has announced that it is partnering with BlueRock Therapeutics, the brainchild of pharma giant Bayer AG (ADR) (OTCMKTS:BAYRY) and Versant Ventures, on cardiac stem cell technologies that it had acquired from the University … |
